Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.

<h4>Background</h4>Tuberculosis (TB) is the leading cause of death from an infectious pathogen worldwide and the most prevalent opportunistic infection in people living with HIV. Isoniazid preventive therapy (IPT) reduces the incidence of active TB and reduces morbidity and mortality in...

Full description

Bibliographic Details
Main Authors: Roy Gerona, Anita Wen, Aaron T Chin, Catherine A Koss, Peter Bacchetti, John Metcalfe, Monica Gandhi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155887&type=printable
_version_ 1826584026269351936
author Roy Gerona
Anita Wen
Aaron T Chin
Catherine A Koss
Peter Bacchetti
John Metcalfe
Monica Gandhi
author_facet Roy Gerona
Anita Wen
Aaron T Chin
Catherine A Koss
Peter Bacchetti
John Metcalfe
Monica Gandhi
author_sort Roy Gerona
collection DOAJ
description <h4>Background</h4>Tuberculosis (TB) is the leading cause of death from an infectious pathogen worldwide and the most prevalent opportunistic infection in people living with HIV. Isoniazid preventive therapy (IPT) reduces the incidence of active TB and reduces morbidity and mortality in HIV-infected patients independently of antiretroviral therapy. However, treatment of latent or active TB is lengthy and inter-patient variability in pharmacokinetics and adherence common. Current methods of assessing adherence to TB treatment using drug levels in plasma or urine assess short-term exposure and pose logistical challenges. Drug concentrations in hair assess long-term exposure and have demonstrated pharmacodynamic relevance in HIV.<h4>Methods</h4>A large hair sample from a patient with active TB was obtained for assay development. Methods to pulverize hair and extract isoniazid were optimized and then the drug detected by liquid chromatography/ tandem mass spectrometry (LC/MS-MS). The method was validated for specificity, accuracy, precision, recovery, linearity and stability to establish the assay's suitability for therapeutic drug monitoring (TDM). Hair samples from patients on directly-observe isoniazid-based latent or active TB therapy from the San Francisco Department of Public Health TB clinic were then tested.<h4>Results</h4>Our LC/MS-MS-based assay detected isoniazid in quantities as low as 0.02ng/mg using 10-25 strands hair. Concentrations in spiked samples demonstrated linearity from 0.05-50ng/mg. Assay precision and accuracy for spiked quality-control samples were high, with an overall recovery rate of 79.5%. In 18 patients with latent or active TB on treatment, isoniazid was detected across a wide linear dynamic range.<h4>Conclusions</h4>An LC-MS/MS-based assay to quantify isoniazid levels in hair with performance characteristics suitable for TDM was developed and validated. Hair concentrations of isoniazid assess long-term exposure and may be useful for monitoring adherence to latent or active TB treatment in the setting of HIV.
first_indexed 2024-04-14T07:49:15Z
format Article
id doaj.art-d6d561ef95db48019905c2794276f8e8
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2025-03-14T15:31:12Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d6d561ef95db48019905c2794276f8e82025-02-25T05:36:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01115e015588710.1371/journal.pone.0155887Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.Roy GeronaAnita WenAaron T ChinCatherine A KossPeter BacchettiJohn MetcalfeMonica Gandhi<h4>Background</h4>Tuberculosis (TB) is the leading cause of death from an infectious pathogen worldwide and the most prevalent opportunistic infection in people living with HIV. Isoniazid preventive therapy (IPT) reduces the incidence of active TB and reduces morbidity and mortality in HIV-infected patients independently of antiretroviral therapy. However, treatment of latent or active TB is lengthy and inter-patient variability in pharmacokinetics and adherence common. Current methods of assessing adherence to TB treatment using drug levels in plasma or urine assess short-term exposure and pose logistical challenges. Drug concentrations in hair assess long-term exposure and have demonstrated pharmacodynamic relevance in HIV.<h4>Methods</h4>A large hair sample from a patient with active TB was obtained for assay development. Methods to pulverize hair and extract isoniazid were optimized and then the drug detected by liquid chromatography/ tandem mass spectrometry (LC/MS-MS). The method was validated for specificity, accuracy, precision, recovery, linearity and stability to establish the assay's suitability for therapeutic drug monitoring (TDM). Hair samples from patients on directly-observe isoniazid-based latent or active TB therapy from the San Francisco Department of Public Health TB clinic were then tested.<h4>Results</h4>Our LC/MS-MS-based assay detected isoniazid in quantities as low as 0.02ng/mg using 10-25 strands hair. Concentrations in spiked samples demonstrated linearity from 0.05-50ng/mg. Assay precision and accuracy for spiked quality-control samples were high, with an overall recovery rate of 79.5%. In 18 patients with latent or active TB on treatment, isoniazid was detected across a wide linear dynamic range.<h4>Conclusions</h4>An LC-MS/MS-based assay to quantify isoniazid levels in hair with performance characteristics suitable for TDM was developed and validated. Hair concentrations of isoniazid assess long-term exposure and may be useful for monitoring adherence to latent or active TB treatment in the setting of HIV.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155887&type=printable
spellingShingle Roy Gerona
Anita Wen
Aaron T Chin
Catherine A Koss
Peter Bacchetti
John Metcalfe
Monica Gandhi
Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
PLoS ONE
title Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
title_full Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
title_fullStr Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
title_full_unstemmed Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
title_short Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.
title_sort quantifying isoniazid levels in small hair samples a novel method for assessing adherence during the treatment of latent and active tuberculosis
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0155887&type=printable
work_keys_str_mv AT roygerona quantifyingisoniazidlevelsinsmallhairsamplesanovelmethodforassessingadherenceduringthetreatmentoflatentandactivetuberculosis
AT anitawen quantifyingisoniazidlevelsinsmallhairsamplesanovelmethodforassessingadherenceduringthetreatmentoflatentandactivetuberculosis
AT aarontchin quantifyingisoniazidlevelsinsmallhairsamplesanovelmethodforassessingadherenceduringthetreatmentoflatentandactivetuberculosis
AT catherineakoss quantifyingisoniazidlevelsinsmallhairsamplesanovelmethodforassessingadherenceduringthetreatmentoflatentandactivetuberculosis
AT peterbacchetti quantifyingisoniazidlevelsinsmallhairsamplesanovelmethodforassessingadherenceduringthetreatmentoflatentandactivetuberculosis
AT johnmetcalfe quantifyingisoniazidlevelsinsmallhairsamplesanovelmethodforassessingadherenceduringthetreatmentoflatentandactivetuberculosis
AT monicagandhi quantifyingisoniazidlevelsinsmallhairsamplesanovelmethodforassessingadherenceduringthetreatmentoflatentandactivetuberculosis